DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1

FDA recall notice · announced March 15, 2023 · Akron Pharma

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Notes

Distribution: Nationwide within the United States
Lot/code information: Lot #: 2206016, Exp. date 05/2024
Quantity: 4,416 tubes
Status: Terminated
Products in this recall event:
- DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1 (D-0454-2023)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.